CompletedPhase 3NCT00350662
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
Studying Hereditary Hemochromatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lipomed
- Principal Investigator
- Amal M El-Beshlawy, Prof. Dr.Pediatric Hospital, Cairo University, Cairo, Egypt
- Intervention
- Deferiprone (L1)(drug)
- Enrollment
- 95 enrolled
- Eligibility
- 4 years · All sexes
- Timeline
- 2002
Study locations (2)
- Pediatric Hospital, Cairo University, Cairo, Egypt
- EGE University Medical School, Bornova, Izmir, İzmir, Turkey (Türkiye)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00350662 on ClinicalTrials.gov